Once a multi-dose vial is punctured with a needle, the sterile barrier is broken
CrossRef The role of the resveratrol-sirtuin axis in the treatment of metabolic dysfunction-associated diseases Jiale Yang, Shuping Chen, Tiantian Zeng, Yuxuan Zhang, Zhaoxin Li, Haifang Li Exploration of Endocrine and Metabolic Diseases .2026;[Epub] CrossRef GLP-1 receptor agonistSGLT-2 inhibitor combination and risk of major adverse liver and cardiovascular outcomes in adults with MASLD and type 2 diabetes Xianhua Mao, Hong Fan, Man-Fung Yuen, Ramsey Cheung, Wai-Kay Seto, Mindie H
Patients generally progress to 0.5 mg for four weeks, followed by 1 mg for another four weeks, with further adjustments depending on efficacy and side effects
however, a new paradigm for HFpEF development proposes that a systemic proinflammatory state, induced by comorbidities, is responsible for these myocardial structural and functional changes [11]